築友智造科技(00726.HK)控股股東擬增持約8.74%股份
格隆匯 7 月 13日丨築友智造科技(00726.HK)發佈公告,恩輝投資有限公司(一間董事會主席、執行董事兼控股股東胡葆森直接全資並實益擁有的公司)知會公司,恩輝及朱嶽海(緊接股份過户前的一位公司股東)於2020年7月13日訂立一份股份購買協議,據此,恩輝同意購買且朱嶽海同意出售公司約9.79億股股份,現金代價總額約為3.03億港元,相當於每股出售股份0.31港元。
出售股份為朱嶽海緊接股份過户前所持的全部公司股份,並佔公司於公告日期全部已發行股本約8.74%。胡葆森對公司未來發展前景及成長潛力有信心,並且不排除將來會於適當時候進一步增加其於公司的持股量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.